Afterimage duration differs for migraine with or without aura
Headache: The Journal of Head and Face Pain · 2025
DOI: 10.1111/head.14934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2025. Verfasst von Florian Rimmele und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Headache Centre North-East, Rostock University Medical Centre, Rostock, Germany. Hauptthemen laut MEDLINE: Migraine with Aura, Migraine without Aura, Afterimage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
It is controversial to what extent afterimages, as distinct visual phenomena, are altered in patients with migraine and whether they have a specific role in migraine pathophysiology.
Objective
The aim of this cross‐sectional study was to investigate the duration of afterimages in patients with migraine, migraine with aura (MwA), and migraine without aura (MwoA), compared to healthy controls (HCs).
Methods
Adults with migraine, MwA, and MwoA, diagnosed according to The International Classification of Headache Disorders, third edition criteria and HCs without relevant headache history were included. Initially, factors affecting the experimental setting of testing afterimage latency were determined. Then, afterimage duration was measured in the two study groups (MwA and MwoA) and the HC group. Patient characteristics, intraocular pressure, and relevant comorbid conditions, as well as scales on depressive symptoms (nine‐item Patient Health Questionnaire) and headache‐specific psychosocial impairment (six‐item Headache Impact Test) were recorded. Lastly, the role of different stimulus colors, as well as habituation effects after repeated stimulation, were investigated.
Results
The main study included 174 participants (40 with MwA, 53 with MwoA, and 81 HCs). The duration of the afterimage in patients with MwA was significantly longer than in HCs, at a mean (standard error of the mean [SEM]) of 12.6 (2.6) versus 5.5 ( 0.3) s ( p = 0.035), while there was no significant difference between patients with MwoA (mean [SEM] 7.7 [1.6] s; p = 0.510) and HCs. There was also no significant effect of stimulus color on afterimage latency (mean [SEM] red: 8.9 [1.2] s and black: 8.4 [1.2] s).
Conclusion
We found significantly longer afterimage duration in patients with MwA compared to both HCs and patients with MwoA. Furthermore, partially selective stimulation of retinal rods and cones by different stimulus colors had no effect on afterimage duration suggesting a relevant subcortical and/or cortical modulation in migraine aura with increased excitability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Headache Centre North-East, Rostock University Medical Centre, Rostock, Germany.
- Institute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
- Institute for Information Systems, Hof University, Hof, Germany.
- Department of Neurology, Headache Centre North-East, KMG Hospital Güstrow, Güstrow, Germany.
Zitieren
APA
Rimmele, F., Teuber, J., Müller, B., Giesen, S., Drescher, J., Scheidt, J., Walter, U., Kropp, P., & Jürgens, T. P. (2025). Afterimage duration differs for migraine with or without aura. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14934
Vancouver
Rimmele F, Teuber J, Müller B, Giesen S, Drescher J, Scheidt J, et al. Afterimage duration differs for migraine with or without aura. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14934
BibTeX
@article{Rimmele2025,
author = {Rimmele, Florian and Teuber, Julia and Müller, Britta and Giesen, Simeon and Drescher, Johannes and Scheidt, Jörg and Walter, Uwe and Kropp, Peter and Jürgens, Tim P},
title = {Afterimage duration differs for migraine with or without aura},
journal = {Headache: The Journal of Head and Face Pain},
year = {2025},
doi = {10.1111/head.14934}
}
EUVIMED